Emergex Vaccines
Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.
Industries
biopharma
biotechnology
health-care
Nr. of Employees
small (1-50)
Patents
MHC class i associated peptides for prevention and treatment of multiple flavi virus
US-12178867-B2
View DetailsMHC class I associated peptides for prevention and treatment of zika virus
US-11931407-B2
View DetailsMHC class I associated peptides for prevention and treatment of multiple flavi virus
US-11690904-B2
View DetailsMHC class I associated peptides for prevention and treatment of zika virus
US-11426457-B2
View DetailsPharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
US-11344614-B2
View Details
MHC class i associated peptides for prevention and treatment of multiple flavi virus
US-12178867-B2
View DetailsMHC class I associated peptides for prevention and treatment of zika virus
US-11931407-B2
View DetailsMHC class I associated peptides for prevention and treatment of multiple flavi virus
US-11690904-B2
View DetailsMHC class I associated peptides for prevention and treatment of zika virus
US-11426457-B2
View DetailsPharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
US-11344614-B2
View Details